Regeneron says its COVID-19 antibody treatment cut medical visits in trial

  • 📰 Reuters
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

Regeneron Pharmaceuticals Inc said on Wednesday its coronavirus antibody cocktail - the experimental treatment that U.S. President Donald Trump received - significantly reduced medical visits in a trial of nearly 800 patients with mild-to-moderate COVID-19.

FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid

The drop was around 72% in patients with one or more risk factors such as being over age 50, obesity, cardiovascular, metabolic, lung, liver or kidney disease, or an immunocompromised status. Regeneron’s drug is a cocktail of two monoclonal antibodies - manufactured copies of antibodies that are one of the main weapons the immune system generates to fight infections.

The company earlier this month filed with the U.S. Food and Drug Administration seeking an EUA for the dual-antibody therapy. It said it has shared the new data with the regulator as part of the review of its request.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

And how much stock does Trump own in this company?

It’s not a vaccine or a cure. This is beyond misleading. Ignorant

Why Not Give Them An EUA Immediatly. So People Can Start Getting Treated With It.

Only works with intravenous

Yay!!!

Placebo ?

don’t have to visit the hospital if you die

Joe Biden is corrupt and a liar.

Really? Which peer reviewer journal are they published in? HOAX!

300000 doses were bought by the govt? So.........only a very select few are going to get this, huh?

Don’t they use stem cells?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Regeneron says its Covid-19 antibody treatment cut medical visits in trialNEW: Regeneron Pharmaceuticals says its coronavirus antibody cocktail, the experimental treatment that President Trump received, significantly reduced medical visits in a trial of nearly 800 patients with mild-to-moderate cases of Covid-19. Wonder which GOP MEMBER has STOCK OPTIONS in this COMPANY. SHOULD BE INVESTIGATED. TRUMP DON JR IVANKA MELANIA? 800 patients is not a FULL TRIAL.... Now tell us the cost per dose! if you ignore the whole liver of the dead aborted fetus thing! Easy swallow for 'pro-lifers'!
Source: NBCNews - 🏆 10. / 86 Read more »

NFL reports 19 new cases of COVID-19The number of positive COVID-19 cases in the NFL stayed even from the previous week, according to numbers released Tuesday by the league and the NFL Players Association. RIP to the grandparents of these players. They would probably have 20 if they were to use one of their thumbs to help with the counting but unfortunately it’s stuck up the BLM arses so they stopped at 19. They need to stop the end of the game covid congratulation love festivals
Source: Reuters - 🏆 2. / 97 Read more »

HHS, DOD Collaborate on Plans to Purchase of Lilly Investigational Therapeutic to Treat COVID-19As part of the Trump Administration’s goal of delivering life-saving vaccines and therapeutics in record time through Operation Warp Speed, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) today announced an agreement with Eli Lilly and Company to purchase the first doses of the company’s COVID-19 investigational antibody therapeutic bamlanivimab, also known as LY-CoV555. These doses will be available for patient care if the U.S. Food and Drug Administration (FDA) authorizes use of the therapeutic, as outlined in agency guidance. DeptofDefense LillyPad That's terrifying... DeptofDefense LillyPad It showed no impact in serious/critical COVID19 and is still in RCTs, so yet another purchase for millions of dollars and a stock market bump on an therapeutic not proven to work that the company will make investors money in wealthy countries. Pathetic.
Source: HHSGov - 🏆 147. / 63 Read more »

Fighting COVID-19 Is A Struggle, Illinois' Public Health Director SaysNPR's David Greene speaks with Illinois Public Health Director Dr. Ngozi Ezike about the spike in COVID-19 cases in her state. She says more people need to wear masks.
Source: NPRHealth - 🏆 144. / 63 Read more »

COVID-19 cases, hospitalizations surge, governors crack downNearly half a million people have contracted COVID-19 in the United States over the last seven days, according to a Reuters tally, as new cases and hospitalizations set records in the Midwest. Nobody’s dying from it!!!!!!! What’s the recovery rate!? This is all a bunch of BS. The Democrats have ruined and destroyed the United States. And deaths have increased by...oh, they haven’t. It is same same deaths reported which are vulnerable and very elderly and Co-morbid. When is this insanity, anti-science going to end. People die - shocking news This is a global issue not a domestic political issue ..
Source: Reuters - 🏆 2. / 97 Read more »

Wisconsin Dairy Farmer Weighs In On The Election, COVID-19 SpikeWhat's on voters' minds in Wisconsin as COVID-19 cases surge in the state? NPR's Noel King talks to dairy farmer Rick Roden of West Bend, who says he's more concerned about his farm than the pandemic.
Source: NPRHealth - 🏆 144. / 63 Read more »